ELAVL1 and cancer: By interacting with miR-3164 and recruiting HuR protein in NPC cells, LINC00324 upregulates the expression of PAD4 to activate the PI3K/AKT pathway, thereby inhibiting autophagy and apoptosis in cancer cells and promoting the development of malignant tumors [242,259,260].